Radboudumc
The "Molecular Therapy for Inherited Retinal Diseases" group, headed by Prof. dr. Rob Collin, and his colleague Dr. Alex Garanto, aims to develop various therapeutic interventions for inherited retinal diseases, with a strong focus on splice modulation and RNA therapies. The laboratory is shared with the group of Dr. Erwin van Wijk that focuses on a better understanding and the development of genetic therapies for inherited hearing impairment and Usher syndrome. The project will be conducted within these two research groups.
The research is embedded at the
Department of Human Genetics within the Radboudumc in Nijmegen, which is internationally renowned for its research and diagnostics on a variety of genetic and genomic disorders. The Department offers an exciting working environment with enthusiastic people from many parts of the world enjoying high quality research.
RadboudumcRadboud university medical center is a university medical center for patient care, scientific research, and education in Nijmegen. Radboud university medical center strives to be at the forefront of shaping the healthcare of the future. We do this in a person-centered and innovative way, and in close collaboration with our network. We want to have
a significant impact on healthcare. We want to improve with each passing day, continuously working towards better healthcare, research, and education. And gaining a better understanding of how diseases arise and how we can prevent, treat, and cure them, day in and day out. This way, every patient always receives the best healthcare, now and in the future. Because that is why we do what we do.
Read more about our
strategy and what
working at Radboud university medical center means.
Our colleagues would be happy to tell you about it.
#weareradboudumc